Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections

Medical Journal of Australia

Volumn 175, Issue 2, 2001, Pages 112-116

  Rawlinson, W D ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMANTADINE; ANTIVIRUS AGENT; CIDOFOVIR; DNA POLYMERASE; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERFERON; MICROSOME ENZYME; NUCLEOSIDE ANALOG; OSELTAMIVIR; PLECONARIL; PROBENECID; RIBAVIRIN; RIMANTADINE; RNA DIRECTED DNA POLYMERASE; SIALIC ACID; SIALIDASE; SIALIDASE INHIBITOR; UNINDEXED DRUG; VALACICLOVIR; VALGANCICLOVIR; VIRUS ANTIGEN; VIRUS DNA; VIRUS MESSENGER RNA; ZANAMIVIR;

ANTIMICROBIAL THERAPY; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; BRONCHOSPASM; CHORIORETINITIS; CLINICAL PHARMACOLOGY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; DRY POWDER; ENTEROVIRUS; ENTEROVIRUS INFECTION; GASTROINTESTINAL SYMPTOM; HEPATITIS C; HEPATITIS C VIRUS; HERPES VIRUS; HERPES VIRUS INFECTION; HERPES ZOSTER; HUMAN; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PICORNAVIRUS INFECTION; RHINOVIRUS; SIDE EFFECT; VIROLOGY; VIRUS MENINGITIS; VIRUS RESISTANCE;

EID: 0035898415     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143544.x     Document Type: Article

References (27)

1. Recent advances in antiviral therapy
2. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections
3. Use of oral neuraminidase inhibitor oseltamivir in experimental human influenza
4. Annual report of the National Influenza Surveillance Scheme, 1999
5. Coadministration of orally inhaled zanamivir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of health volunteers
6. The low potential for drug interactions with zanamivir
7. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: A randomized controlled trial
8. Oseltamivir: A new option for the management of influenza in children
9. Resistance of influenza viruses to neuraminidase inhibitors - A review
10. Recent advances in antiviral agents for treatment of herpesvirus infections
11. Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers
12. Valganciclovir hydrochloride, anticytomegalovirus drug
13. Antiviral therapy for herpes zoster: Randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older
14. The use of flow cytometry to detect antiviral resistance in human cytomegalovirus
15. Treatment of potentially life-threatening enterovirus infections with pleconaril
16. Clinical activity of pleconaril in an experimentally induce coxsackievirus A21 respiratory infection
17. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants
18. Hepatitis C virus: Current understanding and prospects for future therapies
19. Use of high-dose interferon in the treatment of chronic hepatitis C
20. Pathogenesis, natural history, treatment, and prevention of hepatitis C
21. Chronic hepatitis C: Common questions, practical answers
22. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
23. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
24. Pegylated interferon alfa-2a is superior to interferon alfa 2a in improving post-treatment histologic outcome in chronic hepatitis C patients
25. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders